Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

There were statistically significant changes in seasonal 25(OH)D levels.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

During the two year follow-up period, the participants were interviewed by telephone at 30 days, 6 and 24 months, and they were invited for a physical examination at 12 months.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Serum 25(OH)D Is a 2-Year Predictor of All-Cause Mortality, Cardiac Death and Sudden Cardiac Death in Chest Pain Patients from Northern Argentina

Study design awaiting verification · PLoS ONE · 2012

Original publication title

Serum 25(OH)D Is a 2-Year Predictor of All-Cause Mortality, Cardiac Death and Sudden Cardiac Death in Chest Pain Patients from Northern Argentina

Patrycja A. Naesgaard; Ricardo A. León De La Fuente; Stein Tore Nilsen; Leik Woie; Torbjoern Aarsland; Cato Brede; Harry Staines; Dennis W. T. Nilsen

© 2012 Naesgaard et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Vitamin D was shown to be a useful biomarker for prediction of mortality when obtained at admission in chest pain patients with suspected ACS.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Several studies have shown an association between vitamin D deficiency and cardiovascular risk. Vitamin D status is assessed by determination of 25-hydroxyvitamin D [25(OH)D] in serum.

Source: Background

Abstract: What methods does the paper describe?

We assessed the prognostic utility of 25(OH)D in 982 chest-pain patients with suspected acute coronary syndrome (ACS) from Salta, Northern Argentina. 2-year follow-up data including all-cause mortality, cardiac death and sudden cardiac death were analyzed in quartiles of 25(OH)D, applying univariate and multivariate analysis.

Source: Methods

Abstract: Results

There were statistically significant changes in seasonal 25(OH)D levels. At follow-up, 119 patients had died. The mean 25(OH)D levels were significantly lower among patients dying than in long-term survivors, both in the total population and in patients with a troponin T (TnT) release (n = 388). When comparing 25(OH)D in the highest quartile to the lowest quartile in a multivariable Cox regression model for all-cause mortality, the hazard ratio (HR) for cardiac death and sudden cardiac death in the total population was 0.37 (95% CI, 0.19 to 0.73), p = 0.004, 0.23 (95% CI, 0.08 to 0.67), p = 0.007, and 0.32 (95% CI, 0.11 to 0.94), p = 0.038, respectively.

In patients with TnT release, the respective HR was 0.24 (95% CI, 0.10 to 0.54), p = 0.001, 0.18 (95% CI, 0.05 to 0.60), p = 0.006 and 0.25 (95% CI, 0.07 to 0.89), p = 0.033. 25(OH)D had no prognostic value in patients with no TnT release.

Source: Results

Abstract: Conclusion

Vitamin D was shown to be a useful biomarker for prediction of mortality when obtained at admission in chest pain patients with suspected ACS.

Source: Conclusion
Authors’ abstract

Background

Several studies have shown an association between vitamin D deficiency and cardiovascular risk. Vitamin D status is assessed by determination of 25-hydroxyvitamin D [25(OH)D] in serum.

Methods

We assessed the prognostic utility of 25(OH)D in 982 chest-pain patients with suspected acute coronary syndrome (ACS) from Salta, Northern Argentina. 2-year follow-up data including all-cause mortality, cardiac death and sudden cardiac death were analyzed in quartiles of 25(OH)D, applying univariate and multivariate analysis.

Results

There were statistically significant changes in seasonal 25(OH)D levels. At follow-up, 119 patients had died. The mean 25(OH)D levels were significantly lower among patients dying than in long-term survivors, both in the total population and in patients with a troponin T (TnT) release (n = 388). When comparing 25(OH)D in the highest quartile to the lowest quartile in a multivariable Cox regression model for all-cause mortality, the hazard ratio (HR) for cardiac death and sudden cardiac death in the total population was 0.37 (95% CI, 0.19 to 0.73), p = 0.004, 0.23 (95% CI, 0.08 to 0.67), p = 0.007, and 0.32 (95% CI, 0.11 to 0.94), p = 0.038, respectively.

In patients with TnT release, the respective HR was 0.24 (95% CI, 0.10 to 0.54), p = 0.001, 0.18 (95% CI, 0.05 to 0.60), p = 0.006 and 0.25 (95% CI, 0.07 to 0.89), p = 0.033. 25(OH)D had no prognostic value in patients with no TnT release.

Conclusion

Vitamin D was shown to be a useful biomarker for prediction of mortality when obtained at admission in chest pain patients with suspected ACS.

Trial registration

ClinicalTrials.gov NCT01377402

Publication and source details

Original title: Serum 25(OH)D Is a 2-Year Predictor of All-Cause Mortality, Cardiac Death and Sudden Cardiac Death in Chest Pain Patients from Northern Argentina

Patrycja A. Naesgaard; Ricardo A. León De La Fuente; Stein Tore Nilsen; Leik Woie; Torbjoern Aarsland; Cato Brede; Harry Staines; Dennis W. T. Nilsen

PLoS ONE · 2012

* E-mail: patrycja_anna_szczepaniak@hotmail.com

Competing Interests: The authors have declared that no competing interests exist.

Conceived and designed the experiments: PAN RLF STN LW TA DN. Performed the experiments: PAN RLF CB. Analyzed the data: PAN RLF CB HS DN. Contributed reagents/materials/analysis tools: PAN RLF TA CB DN. Wrote the paper: PAN RLF STN LW TA CB HS DN. Approved the final version to be published: PAN RLF STN LW TA CB HS DN.

© 2012 Naesgaard et al2012Naesgaard et alhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.This work was funded by a research grant from Stavanger University Hospital to PAN. This funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T13:58:46.088021+00:00

DOI: 10.1371/journal.pone.0043228 · PMC3435385